Identification of biomarkers for the early detection of non-small cell lung cancer: a systematic review and meta-analysis
Carcinogenesis · 12.02.2024 · 45 (1-2) · 1-22
DOI: 10.1093/carcin/bgad091 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Carcinogenesis, online erschienen am 08.12.2023. Verfasst von Eithar Mohamed und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Biomedicine, Hull York Medical School, University of Hull, Kingston-upon-Hull, HU6 7RX, UK. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, MicroRNAs. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 146 Literaturangaben. Gefördert von: University of Hull.
Abstract (Originalsprache)
Lung cancer (LC) causes few symptoms in the earliest stages, leading to one of the highest mortality rates among cancers. Low-dose computerised tomography (LDCT) is used to screen high-risk individuals, reducing the mortality rate by 20%. However, LDCT results in a high number of false positives and is associated with unnecessary follow-up and cost. Biomarkers with high sensitivities and specificities could assist in the early detection of LC, especially in patients with high-risk features. Carcinoembryonic antigen (CEA), cytokeratin 19 fragments and cancer antigen 125 have been found to be highly expressed during the later stages of LC but have low sensitivity in the earliest stages. We determined the best biomarkers for the early diagnosis of LC, using a systematic review of eight databases. We identified 98 articles that focussed on the identification and assessment of diagnostic biomarkers and achieved a pooled area under curve of 0.85 (95% CI 0.82–0.088), indicating that the diagnostic performance of these biomarkers when combined was excellent. Of the studies, 30 focussed on single/antigen panels, 22 on autoantibodies, 31 on miRNA and RNA panels, and 15 suggested the use of circulating DNA combined with CEA or neuron-specific enolase (NSE) for early LC detection. Verification of blood biomarkers with high sensitivities (Ciz1, exoGCC2, ITGA2B), high specificities (CYFR21-1, antiHE4, OPNV) or both (HSP90α, CEA) along with miR-15b and miR-27b/miR-21 from sputum may improve early LC detection. Further assessment is needed using appropriate sample sizes, control groups that include patients with non-malignant conditions, and standardised cut-off levels for each biomarker.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Biomedicine, Hull York Medical School, University of Hull, Kingston-upon-Hull, HU6 7RX, UK.
- Department of Biotechnology, Pozuelo de Alarcón, University Francisco De Vitoria, Madrid, 28223, Spain.
- Research Centre for Evidence-Based Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
- Alice Lee Centre for Nursing Studies, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117597, Singapore.
- Respiratory Medicine, Hull York Medical School, University of Hull, Kingston-upon-Hull, HU6 7RX, UK.
ORCID-Profile: Si Qi Yoong, Barbara-Ann Guinn
Förderung
- University of Hull
Zitieren
APA
Mohamed, E., García Martínez, D. J., Hosseini, M. S., Yoong, S. Q., Fletcher, D., Hart, S., & Guinn, B. A. (2024). Identification of biomarkers for the early detection of non-small cell lung cancer: a systematic review and meta-analysis. Carcinogenesis, 45(1-2), 1-22. https://doi.org/10.1093/carcin/bgad091
Vancouver
Mohamed E, García Martínez DJ, Hosseini MS, Yoong SQ, Fletcher D, Hart S, et al. Identification of biomarkers for the early detection of non-small cell lung cancer: a systematic review and meta-analysis. Carcinogenesis. 2024;45(1-2):1-22. doi:10.1093/carcin/bgad091
BibTeX
@article{Mohamed2024,
author = {Mohamed, Eithar and García Martínez, Daniel J and Hosseini, Mohammad-Salar and Yoong, Si Qi and Fletcher, Daniel and Hart, Simon and Guinn, Barbara-Ann},
title = {Identification of biomarkers for the early detection of non-small cell lung cancer: a systematic review and meta-analysis},
journal = {Carcinogenesis},
year = {2024},
volume = {45},
number = {1-2},
pages = {1--22},
doi = {10.1093/carcin/bgad091}
}
EUVIMED